Schwaig, Germany

Istvan Szeleny


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1986-1991

Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Innovator Istvan Szeleny: A Pioneer in Medicinal Chemistry**

Introduction

Istvan Szeleny is a distinguished inventor based in Schwaig, Germany. With a focus on medicinal chemistry, he holds two patents that reflect his significant contributions to the field. His innovative work aims to develop novel compounds that have potential therapeutic applications.

Latest Patents

The first patent is centered around pyrimidine-thioalkyl pyridine derivatives. This invention describes compounds that fall under a specific general formula, where various substituents represent hydrogen, lower alkyl, halogen, amino, or hydroxy groups. The pyrimidine-thioalkyl group can be positioned at various points on the pyridine ring, which may lead to new medicaments that are therapeutically compatible. The second patent focuses on quinazoline derivatives, which are characterized by their unique mono- to trisubstituted 5-ring heterocycles. This invention also encompasses the processes for producing these derivatives and the medicaments containing them.

Career Highlights

Istvan Szeleny is employed at Ludwig Heumann & Co. GmbH, where he has dedicated his expertise to pushing the boundaries of medicinal chemistry. His work has not only resulted in innovative compounds but also in practical applications that can significantly benefit healthcare.

Collaborations

Throughout his career, Szeleny has collaborated with notable colleagues, including Kurt H. Ahrens and Helmut Schickaneder. These collaborations have undoubtedly enriched his research and contributed to the successful development of his patented compounds.

Conclusion

Istvan Szeleny exemplifies the spirit of innovation in the field of medicinal chemistry. His patents not only highlight his inventiveness but also his commitment to improving health outcomes through scientific advancements. As he continues his work at Ludwig Heumann & Co. GmbH, we can anticipate further contributions that may lead to groundbreaking developments in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…